中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2013年
9期
1484-1485
,共2页
西乐葆%超前镇痛%髋关节置换
西樂葆%超前鎮痛%髖關節置換
서악보%초전진통%관관절치환
Celebrex%Preemptive Analgesia%Hip Replacement
目的：探讨在髋关节置换患者中应用西乐葆超前镇痛的临床疗效。方法：选取2011年1月至2013年1月间于我院行髋关节置换术的患者110例，按其诊治顺序进行编号并随机分为对照组(55例)和观察组(55例)，给予对照组患者常规术前准备，在对照组基础上给予观察组患者西乐葆超前镇痛，观察两组各临床观察指标。结果：观察组患者手术结束时、术后1h VAS评分与对照组患者无明显差异，在统计学上无意义(P>0.05)；观察组患者术后4h、8h、12h、24h、48hVAS评分均明显高于对照组患者相应指标，组间差异在统计学上均有意义(P<0.05)；观察组不良反应发生率5.45%，而其满意度96.36%，对照组不良反应发生率为14.55%，满意度为80.09%，以上组间差异均具有统计学意义(P<0.05)。结论：西乐葆超前镇痛能够明显缓解髋关节置换患者术后疼痛程度，减少术后镇痛药应用，降低并发症发生，改善预后及转归，值得推广。
目的：探討在髖關節置換患者中應用西樂葆超前鎮痛的臨床療效。方法：選取2011年1月至2013年1月間于我院行髖關節置換術的患者110例，按其診治順序進行編號併隨機分為對照組(55例)和觀察組(55例)，給予對照組患者常規術前準備，在對照組基礎上給予觀察組患者西樂葆超前鎮痛，觀察兩組各臨床觀察指標。結果：觀察組患者手術結束時、術後1h VAS評分與對照組患者無明顯差異，在統計學上無意義(P>0.05)；觀察組患者術後4h、8h、12h、24h、48hVAS評分均明顯高于對照組患者相應指標，組間差異在統計學上均有意義(P<0.05)；觀察組不良反應髮生率5.45%，而其滿意度96.36%，對照組不良反應髮生率為14.55%，滿意度為80.09%，以上組間差異均具有統計學意義(P<0.05)。結論：西樂葆超前鎮痛能夠明顯緩解髖關節置換患者術後疼痛程度，減少術後鎮痛藥應用，降低併髮癥髮生，改善預後及轉歸，值得推廣。
목적：탐토재관관절치환환자중응용서악보초전진통적림상료효。방법：선취2011년1월지2013년1월간우아원행관관절치환술적환자110례，안기진치순서진행편호병수궤분위대조조(55례)화관찰조(55례)，급여대조조환자상규술전준비，재대조조기출상급여관찰조환자서악보초전진통，관찰량조각림상관찰지표。결과：관찰조환자수술결속시、술후1h VAS평분여대조조환자무명현차이，재통계학상무의의(P>0.05)；관찰조환자술후4h、8h、12h、24h、48hVAS평분균명현고우대조조환자상응지표，조간차이재통계학상균유의의(P<0.05)；관찰조불량반응발생솔5.45%，이기만의도96.36%，대조조불량반응발생솔위14.55%，만의도위80.09%，이상조간차이균구유통계학의의(P<0.05)。결론：서악보초전진통능구명현완해관관절치환환자술후동통정도，감소술후진통약응용，강저병발증발생，개선예후급전귀，치득추엄。
Objective:To investigate the clinical efficacy of celebrex preemptive analgesia in hip replacement patients.Methods:Selectting 110 patients in our hospital with the hip replacement surgery from January 2011 to January 2013, randomly divided into control group (55 cases) and observation group (55cases) by their diagnosis and treatment order number, the control group patients preoperative preparation, the celebrex preemptive analgesia in the observation group were given on the basis of the control group, observed two the group clinical observation indicators.Results:The patients the end of surgery, postoperative 1h VAS score with the control group patients were no significant difference (P>0.05) ;The observation group patients in 4h,8h,12h,24h,48hVAS score were significantly higher in patients with the control group’s, the differences between groups were statistically significant (P<0.05);The adverse reaction rate of the observation group was 5.45%, and satisfaction rate was 96.36%, the adverse reaction rate of the control group was 14.55%, satisfaction rate was 80.09%, the difference between the above group were statistically significant (P<0.05).Conclusion:The celebrex preemptive analgesia can significantly alleviate hip replacement in patients with postoperative pain and reduce postoperative analgesic applications, reduce complications and improve the prognosis, is worth promoting.
